Prospective Collection of Whole Blood Specimens From RhD Negative Pregnant Women

Launched by DEVYSER INC. · Nov 13, 2024

Keywords

ClinConnect Summary

This clinical trial is focused on collecting blood samples from pregnant women who are RhD negative, which means they do not have a specific protein on their red blood cells. The goal is to use these samples for future research to develop safer and easier tests that can determine the Rh blood type of babies before they are born. This research could help improve care for both mothers and their babies during pregnancy.

To be eligible for this study, women must be 18 years or older and currently pregnant, with a heartbeat detected in the baby. They should also be able to provide consent to participate and have a documented RhD negative blood type. Unfortunately, women who are pregnant with more than one baby (like twins or triplets) cannot join the study. If you participate, you will be asked to provide a blood sample and information about your baby's blood type after birth. This is a great opportunity to contribute to important research that could benefit future pregnancies!

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Willing and able to provide written informed consent
• • 2. 18 years of age or older at enrollment
• • 3. Women with a viable pregnancy (with documented fetal heartbeat) between 12 weeks, 0 days and 28 weeks, 0 days gestational age
• • 4. Women with RhD negative antigen status by serology
• • 5. Willing to provide neonatal ABO and RhD genotyping status
• Exclusion Criteria:
• • 1. Women with multiple gestation pregnancy